As illustrated on the world map, the company’s extensive international patent portfolio includes two significant patent families, 34 issued patents, and many pending patent applications across the United States, Canada, Mexico, Brazil, Europe, United Kingdom, Switzerland, China, Russia, India, Japan, South Korea, Indonesia, Philippines, Australia, New Zealand and other jurisdictions.
The first patent family covers very-low-nicotine cigarettes comprising blends of very-low-nicotine tobacco and hemp, and the second covers vaporizer pods (for electronic vaporizers) also comprising blends of tobacco and hemp. Patents are issued or filed in countries where more than half of the world’s one billion plus cigarette smokers and vapers reside.
The company’s reduced-nicotine cigarettes in development are for assisting in smoking less and/or facilitating smokers to switch to less harmful, smoke-free products such as Vuse® e-cigarettes or IQOS®, and upon commercialization, the company’s vaporizer pods. If you’re interested in licensing or investment opportunities, please contact us.
At Cabbacis, we thrive on continuous innovation, developing and implementing new technologies to bring innovative product solutions to market.
This webpage is provided to satisfy the virtual patent marking provisions of the United States in accordance with Section 287(a) of Title 35 of the United States Code and of various international jurisdictions. Notice is hereby given that the products of Cabbacis LLC are protected by a variety of intellectual property rights including issued patents and pending patent applications, and similar rights, details of which are provided below.
United States:
11,017,689
10,878,717
Australia:
2019312297
2021245244
Brazil:
BR112021001449-7
BR122021016119-4
Canada:
3,107,796
China:
201980058557.1
Hong Kong:
HK40047021
Indonesia:
P-00 2021 01078
Macau:
J/006113(836)
Japan:
6975872
6975870
Mexico:
388607
New Zealand:
773380
Russia:
2768862
South Korea:
10-2334194
United States:
10,777,091
10,973,255
Australia:
2020346810
Brazil:
BR112022004480-1 A2
Canada:
3,151,047
Europe:
EP4027814 - Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Slovenia, Sweden
Hong Kong:
HK40077323 B
New Zealand:
787184
Japan:
7148756
Mexico:
397,143
New Zealand:
773380
South Korea:
10-2519563
Spain:
E20863857
Switzerland:
4027814
United Kingdom:
4027814
United States Patent No. 10,897,925
United States Patent No. 10,820,624
Cabbacis also owns various pending patent applications in the U.S. and internationally.
iBlend is a trademark of Cabbacis LLC registered in the United States, Canada, Mexico, Brazil, European Union, United Kingdom, Switzerland, Russia, China, Japan, South Korea, India, Indonesia, Philippines, Australia and New Zealand.
Cabbacis is a trademark of Cabbacis LLC registered in the United States, Canada, Mexico, European Union, United Kingdom, China, India, Australia and New Zealand.
Copyright ©2025
Under the Copyright Law, Title 17 of the United States of America and equivalent or similar laws in other jurisdictions, no unauthorized duplication, reproduction, use, distribution of website authorship work products are allowed, without the express and written consent of the sole owner, Cabbacis LLC.